ArticleBMC geriatrics2026
Association between cognitive function and all-cause mortality among US older adults with cardiovascular-kidney-metabolic syndrome.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCardiovascular-kidney-metabolic syndrome (CKM) is associated with an increased risk of mortality among older adults, but the relationship between cognitive function and mortality across different stages of CKM remains unclear. This study investigated the associations between cognitive performance and all-cause mortality among older adults with different stages of CKM syndrome.
methodsThe current cohort analyzed data from 1155 United States older adults aged ≥ 60 years. Cognitive function was measured using typical cognitive tests. Participants were classified into non-advanced CKM and advanced CKM groups. Weighted regression models were used to explore the association between cognitive function and mortality.
resultsFollowing full adjustment for potential confounders, higher cognitive function scores were associated with a decreased risk of all-cause mortality risk in both advanced and non-advanced CKM groups. The highest quartile group exhibited a decreased risk of mortality in cognitive tests ( hazard ratio < 1, P < 0.05). Significant interactions were observed between subgroups of cognitive scores, smoking status, and body mass index.
conclusionImproving cognitive function may lower the risk of mortality among older adults with non-advanced CKM and advanced CKM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.